Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 

VICC toll-free number 1-877-936-8422

Clinical Trials for Daniel Barocas

1 Open Trial

Trial Type Protocol No. &
Open Date
Summary

Treatment

VICCURO1559

09/02/2015

An Open Label, Single Arm, Phase II, Multicenter Study of the Safety and Efficacy of CG0070 Oncolytic Vector Regimen in Patients with Non-Muscle Invasive Bladder Carcinoma Who have Failed BCG Therapy and Refused Cystectomy